We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-12.36%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$12.7B
AUM Growth
-$3.96B
Cap. Flow
-$1.66B
Cap. Flow %
-13.11%
Top 10 Hldgs %
14.02%
Holding
2,200
New
84
Increased
771
Reduced
1,166
Closed
158
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LAZR
1826
DELISTED
Luminar Technologies
LAZR
$269K ﹤0.01%
3,023
+249
+9% +$39.8K
OBDC icon
1827
Blue Owl Capital
OBDC
$5.58B
$269K ﹤0.01%
21,817
+557
+3% +$7.63K
VRTS icon
1828
Virtus Investment Partners
VRTS
$1.09B
$268K ﹤0.01%
1,564
+611
+64% +$115K
NVEE
1829
DELISTED
NV5 Global
NVEE
$267K ﹤0.01%
+9,156
New +$274K
DXPE icon
1830
DXP Enterprises
DXPE
$3.07B
$266K ﹤0.01%
8,670
+637
+8% +$17.5K
KFY icon
1831
Korn Ferry
KFY
$4.2B
$266K ﹤0.01%
+4,584
New +$278K
BTX
1832
BlackRock Technology and Private Equity Term Trust
BTX
$982M
$265K ﹤0.01%
33,393
+11,798
+55% +$106K
TNET icon
1833
TriNet
TNET
$3.06B
$264K ﹤0.01%
3,394
-113
-3% -$9.44K
GBDC icon
1834
Golub Capital BDC
GBDC
$3.39B
$263K ﹤0.01%
20,264
+618
+3% +$8.85K
GBX icon
1835
The Greenbrier Companies
GBX
$1.48B
$263K ﹤0.01%
7,304
+315
+5% +$13.2K
GWRE icon
1836
Guidewire Software
GWRE
$13.3B
$263K ﹤0.01%
+3,703
New +$303K
ORGO icon
1837
Organogenesis Holdings
ORGO
$310M
$263K ﹤0.01%
53,957
+27,700
+105% +$171K
PBA icon
1838
Pembina Pipeline
PBA
$27.9B
$263K ﹤0.01%
+7,437
New +$286K
TAK icon
1839
Takeda Pharmaceutical
TAK
$54.4B
$263K ﹤0.01%
18,715
-2,007
-10% -$28.6K
CATO icon
1840
Cato Corp
CATO
$65.9M
$261K ﹤0.01%
22,522
+2,185
+11% +$28.7K
JWN
1841
DELISTED
Nordstrom
JWN
$260K ﹤0.01%
12,290
-1,711
-12% -$43.7K
OMAB icon
1842
Grupo Aeroportuario Centro Norte
OMAB
$5.37B
$260K ﹤0.01%
5,083
+1,105
+28% +$62.9K
VBTX
1843
DELISTED
Veritex Holdings
VBTX
$259K ﹤0.01%
8,871
+2,685
+43% +$89.4K
ACLS icon
1844
Axcelis
ACLS
$4.2B
$258K ﹤0.01%
4,697
+1,460
+45% +$84.6K
TXG icon
1845
10x Genomics
TXG
$5.79B
$258K ﹤0.01%
5,710
+519
+10% +$26.9K
MED icon
1846
Medifast
MED
$136M
$257K ﹤0.01%
+1,423
New +$255K
ARQT icon
1847
Arcutis Biotherapeutics
ARQT
$3.32B
$256K ﹤0.01%
12,016
-250
-2% -$5.13K
SPCE icon
1848
Virgin Galactic
SPCE
$377M
$255K ﹤0.01%
2,118
+157
+8% +$22.8K
TSLX icon
1849
Sixth Street Specialty
TSLX
$1.78B
$254K ﹤0.01%
13,715
+359
+3% +$7.6K
LGIH icon
1850
LGI Homes
LGIH
$1.38B
$251K ﹤0.01%
2,889
+804
+39% +$74.5K

Similar funds

Guggenheim Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Guggenheim Capital held 2,200 positions worth $12.7B, down 24% from $16.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Guggenheim Capital withdrew a net $1.66B in Q2 2022, closing 158 positions and reducing 1,166 holdings. Its most notable exit was BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC, an estimated $13.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Guggenheim Capital opened a new position in ESAB worth $3.14M.

  • Guggenheim Capital's largest Q2 2022 buy was ESAB: 71,750 shares worth $3.14M.
  • Guggenheim Capital added most to Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q2 2022, an estimated $25.1M increase.
  • Guggenheim Capital's biggest Q2 2022 reduction was Apple, cutting an estimated $68.5M.
  • Guggenheim Capital fully exited BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC in Q2 2022, selling an estimated $13.1M.
  • Guggenheim Capital's ten largest holdings make up 14% of its $12.7B portfolio in Q2 2022.
  • Guggenheim Capital opened 84 new positions and closed 158 in Q2 2022.
  • Guggenheim Capital's portfolio value fell 24% quarter-over-quarter to $12.7B.

Based on Guggenheim Capital's 13F filing for Q2 2022, filed 15 Aug 2022.